Hyaluronan, or hyaluronic acid (HA) is a linear, highmolecular-weight (mega-Dalton) polymer comprised of repeating disaccharide units of (β1→3)D-glucuronate-(β1→4)N-acetyl-D-glucosamine. HA is synthesized by integral plasma membrane glycosyltransferases and is exported directly into the extracellular space (1, 2). Although HA is chemically homogeneous, there are three distinct mammalian HA synthases (designated Has1, Has2, and Has3), encoded by related but nonlinked genes (3-9). Each synthase has distinct catalytic properties, and the distribution and abundance of each varies during development of the mouse (6, 10). These observations suggest that the different Has enzymes play distinct roles.
geted deletion of the Has2 gene results in embryonic death at approximately E9.5, with extensive abnormalities of the developing cardiovascular system. HA is virtually absent in Has2 -/-E9.5 embryos, demonstrating that Has2 is the principal source of HA during initial organogenesis in the mouse. Interestingly, the Has2 -/-embryo closely resembles that of heart defect (hdf) mice lacking the HA-binding proteoglycan versican, showing that a composite matrix requiring HA and versican is essential for forming cardiac jelly to support cushion morphogenesis and subsequent cardiac development. Our studies also reveal a striking role for HA in cell migration and transformation. The use of a well-established explant system revealed absent cell migration and epithelium-to-mesenchyme transformation in the atrioventricular (AV) canal from Has2 -/-embryos. Normal transformation is rescued by Has2 cDNA or the addition of purified HA. The requirement for HA in endothelial migration and transformation is abrogated by the expression of constitutively active H-Ras, and rescue by HA is inhibited by dominant-negative H-Ras. Thus, HA plays two complementary roles in development: expansion of the extracellular space, providing a hydrated matrix for cell migration; and stimulation of an invasive phenotype by cardiac endothelial cells.
Methods
In situ hybridization. In situ hybridization was performed using a full-length Has2 cDNA riboprobe (9) as described (63) . To detect versican mRNA we used a 348-bp fragment spanning the boundary between exons 6 and 8, detecting the VI splice form. Embryos were fixed in RNase-free 4% paraformaldehyde (PFA) and then embedded in paraffin. Serial sections were cut and deparaffinized. Riboprobes were labeled with 35 S-UTP (NEN Life Science Products Inc., Boston, Massachusetts, USA) using T3 or T7 polymerase (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA). Sections were then hybridized with the indicated probes in 0.02% Ficoll 400, 0.02% polyvinylpyrrolidone, 0.1% BSA, 100 µg/mL denatured salmon-sperm DNA, 100 µg/mL yeast RNA, and 10% dextran sulfate at 50°C for 16 hours. Hybridized sections were rinsed first in a formamide wash buffer for 30 minutes at 50°C, then in 0.5× SSC for 30 minutes at 25°C. Unhybridized probe was removed by digestion with RNase A, followed by two 1-hour washes in 0.1× SSC at 65°C. The sections were dehydrated, and autoradiography was performed using Kodak NTB-2 emulsion, Kodak Developer D-19, and Rapid Fix (Eastman Kodak Co., Rochester, New York, USA).
Histology. Embryos were fixed in 4% PFA alone or 4% PFA with 0.5% cetylpyridinium chloride (17) , and then stained with hematoxylin and eosin or acidic alcian blue. HA was detected with 4 µg/mL of biotinylated HAbinding (b-PG) domains isolated from bovine nasal cartilage (64) (generously provided by Charles Underhill, Georgetown University Medical School, Washington, DC, USA). The b-PG was detected using streptavidinconjugated horseradish peroxidase and 3,3′-diaminobenzidine (DAB). Incubating b-PG with 0.1 mg/mL HA for 1 hour at room temperature before use abolished staining, demonstrating specificity for HA.
Whole-mount immunohistochemistry. Embryos were fixed in 4% PFA overnight at 4°C, dehydrated into methanol (25°C), and incubated in 5% H 2 O 2 and 95% methanol at 25°C for 5 hours. Embryos were rehydrated and placed in a solution of 3% nonfat milk, 0.1% Triton X-100, and PBS (PBSMT) at 25°C for 2 hours with one change. Embryos were incubated with 10 µg/mL anti-mouse CD31 (platelet endothelial-cell adhesion molecule, or PECAM) (PharMingen, San Diego, California, USA) in PBSMT overnight at 4°C. They were then washed with PBSMT five times, and incubated with a 1:100 dilution of goat anti-rat IgG-horseradish peroxidase conjugate (Kirkegaard and Perry Laboratories Inc., Gaithersburg, Maryland, USA) in PBSMT at 4°C overnight. Next, the embryos were washed in PBSMT six times and rinsed in PBS containing 0.1% Triton X-100 for 20 minutes, followed by the addition of 0.3 mg/mL of DAB substrate (Sigma Chemical Co., St. Louis, Missouri, USA) in PBS containing 0.5% NiCl 2, 0.1% Triton-X100 and 0.2% BSA. This was allowed to stand for 5 minutes at room temperature. Finally, embryos were washed in PBS containing 0.1% Triton-X100 and 0.2% BSA, postfixed in PFAglutaraldehyde, and transferred into 50% glycerol in PBS and then 70% glycerol in PBS. Images were taken with a Leica M3Z inverted microscope.
Microdissection and scanning electron microscopy. Embryos were fixed with 2% glutaraldehyde and 1% PFA in 1% cacodylate buffer. The chest wall and the pericardium were dissected free, and the embryos were postfixed in 2% OsO 4 , washed in 0.2 M cacodylate buffer (pH 7.3), and then dehydrated through graded ethanols and critical-point dried (Tousimis Samdri-PVT-3B; Tousimis, Rockville, Maryland, USA). Specimens were mounted on scanning electron microscopy tubes and ion spattered with 300-nm gold (SEM Coating System; Bio-Rad Laboratories Inc., Hercules, California, USA). The specimens were examined in a JEOL JSM-6300V scanning electron microscope (JEOL U.S.A., Boston, Massachusetts, USA). For section-directed analysis, embryos were processed essentially as described (65) .
Gene targeting. The Has2-targeting vector was created by ligating a 1.6-kb HindIII fragment (short arm of homology) containing exon 3 into the unique HindIII site at the 3′ end of the PGK-Neo cassette (EcoRI-HindI-II fragment of pGK-1) in pBluescript. A 4-kb EcoRI fragment (long arm of homology) extending from a site 60 codons into exon 4 to a site immediately downstream of the 3′ untranslated region was ligated into the EcoRI site located at the 5′ end of the PGK-Neo cassette. A 2.2-kb NotI cassette containing the diphtheria toxin A chain was added to the ends of both arms of homology to facilitate negative selection. The plasmid was linearized with SacII and electroporated into GK129 ES cells (25) . Cells were selected with G418 (66) . G418-resistant clones were screened by PCR with primers for the PGKNeo cassette and the sequence flanking the1.6-kb HindIII short arm of homology (Figure 2 ). Southern analysis of BamHI and EcoRI genomic DNA digests used probes from the 5′ (box 1 in Figure 2a ) and 3′ flanking regions (box 2 in Figure 2a ). Two correctly targeted ES cell clones were expanded, microinjected into C57BL/6J blastocysts, and transferred to the uteri of pseudopregnant CD1 female mice. Chimeric animals were backcrossed onto a C57BL/6J background to screen for germline transmission. Tail biopsy or yolk sac genomic DNAs were amplified by PCR with primers specific for the wild-type allele and the targeted allele (Has2 wildtype 5′: GGCCTGCCAGTCTTATTTTGGCTG; Has2 wildtype 3′: GTAGAAGAGCTGGATGACTGTGGC; targeted allele: PGK-Neo 5′: GAGGCCACTTGTGTAGCGCCAAG; and Has2 wild-type 3′).
AV canal endocardial cushion morphogenesis assay. The AV canal ("explant") from E9.5 wild-type and mutant embryos was placed on a type I collagen gel (rat tail collagen, Sigma Chemical Co.) (32) and grown in a culture medium of 0.1 mL of Medium 199 supplemented with 1% FBS (HyClone Laboratories, Logan, Utah, USA), 100 U/mL penicillin, 100 µg/mL streptomycin, and 0.1% each insulin, transferrin, and selenium (GIBCO BRL, Grand Island, New York, USA) in fourwell microculture dishes (Nalge Nunc International, Naperville, Illinois, USA) at 37°C in 5% CO 2 for 48-72 hours. Explants were supplemented with HA, either by adding to the medium 0.75 mg/mL of HA (mean mol wt: 757,000; Calbiochem-Novabiochem Co., San Diego, California, USA) dialyzed against serum-free culture medium, or by incorporating 0.25 mg/mL HA into the collagen gel. (Boiling the HA before use had no effect upon cell migration or invasion.) Independent experiments were repeated a minimum of five times. Transformation of endothelium to mesenchyme and invasion into the collagen gel was scored from 0 to 4 (67) . A score of 0 represents AV explants with no cell migration. With migration and transformation present, 1 represents 1-20 cells; 2, 21-50 cells; 3, 51-99 cells; and 4 represents ≥ 100 cells. Scoring was performed by observers who did not know the experimental conditions. Interobserver error was less than 0.5 units. Statistical analysis used the Wilcoxon's rank sum test. Extensive invasion of the collagen gel in Has2 -/-rescued explants was confirmed by 3D reconstruction of laser scanning confocal microscopy of explants (data not shown).
AV canal explants were transfected using inactivated adenovirus (68) . Plasmids encoding cytomegalovirusdriven, constitutively active H-Ras (Q61L) and dominant-negative H-Ras (S17N) were purchased from Upstate Biotechnology Inc. (Lake Placid, New York, USA). After overnight incubation to allow attachment, each explant was incubated with 4.2 × 10 7 viral particles mixed with 1 µg of plasmid DNA in Opti-MEM (GIBCO BRL) for 2.5 hours at 37°C. Medium was aspirated and replaced with culture medium. AV explants were cultured for an additional 48 hours and then assessed as indicated. 
Fluorophore-assisted carbohydrate electrophoresis analysis.
Glucose, HA, chondroitin sulfate, and dermatan sulfate were quantified by fluorophore-assisted carbohydrate electrophoresis (FACE; Glyko Inc., Novato, California, USA) analysis (69, 70) . Embryos were digested with 125 µg/mL proteinase K (GIBCO BRL) in 0.0005% phenol red and 0.1 M ammonium acetate (pH 7.0) at 60°C for 4 hours. Embryos were then lyophilized, dissolved in the same buffer, and redigested for 4 hours at 37°C with 100 mU/mL each of hyaluronidase SD and chondroitinase ABC (Seikagaku Corp., Tokyo, Japan). 2-aminoacridone (0.5 µM; Molecular Probes Inc., Eugene, Oregon, USA) in DMSO and glacial acetic acid (85:15) was added, and the mixture was incubated for approximately 16 hours at 37°C. Samples were reduced with NaCNBr (50 µM) (Sigma-Aldrich, St. Louis, Missouri, USA). Fluorescent disaccharides were separated on a MONO composition gel in MONO gel running buffer (Glyko Inc.) for 80 minutes at 500 V, at 4°C. The gel was imaged at 365 nm using a cooled CCD camera (Roper Scientific MASD Inc., Tucson, Arizona, USA), and was analyzed using Gel-Pro Analyzer 3.0 software (Media Cybernetics LP, Silver Spring, Maryland, USA). FACE analysis was performed on four individual embryos (two wild-type and two Has2 -/-), as well as on pooled wild-type (n = 6) and Has2 -/-(n = 4) embryos.
Results
Has2 expression during mouse development. Has2 mRNA is expressed at least from E7.5 through birth in the mouse (6) . At day E8.5, Has2 mRNA is localized predominantly in the epithelium of the foregut diverticulum, cephalic mesenchyme, the allantois, and in the myocardium and endocardium of the heart (data not shown). At E9.5, the distribution of Has2 and versican mRNAs are very similar, with prominent expression in cephalic, foregut, and periaortic mesenchyme; the septum transversum; and the cardiovascular system (Figure 1, a-d ). Has2 and versican mRNAs were present in atrial and ventricular endothelium. Versican mRNA was expressed in myocardium as well, whereas Has2 mRNA was less abundant, except in the myocardium of the AV canal region. In the heart at E9.5, cardiac jelly is rich in HA ( Figure 1f ) and versican ( Figure 1g ). By E10.5, endothelial cells in the AV canal and outflow tract transform into mesenchymal cells and invade the underlying matrix. The migrating cells express high levels of Has2 mRNA ( Figure 1h ) and stain strongly for extracellular HA (Figure 1f , inset). Later, Has2 mRNA is expressed by mesenchymal cells during elevation of the secondary palate and by hypertrophic chondrocytes within epiphysial growth plates (data not shown); this is consistent with a role for Has2-dependent HA synthesis in the expansion of soft tissues and in chondrogenesis (24) . The relatively high level of expression of Has2 mRNA and its presence at sites of HA accumulation suggest that Has2 is a major source of HA during organogenesis.
Targeted inactivation of the Has2 gene. The replacement vector disrupts the coding sequence of Has2 by inserting a PGK-Neo cassette into the locus (Figure 2 ). This deleted a portion of intron 3 (including the splice acceptor) and the first 60 codons of exon 4, which encodes part of the cytoplasmic catalytic domain of Has2. The resultant allele encodes a truncated, enzymatically inactive protein. The replacement vector was introduced into the GK129 ES cells (25) and mice by standard methods (26) . Mice heterozygous for the targeted allele were fertile and exhibited no obvious abnormalities. Heterozygous intercrosses yielded no viable offspring that were homozygous for the targeted allele (Has2 -/-), consistent with a lethal embryonic phenotype ( Table 1 ). The first Has2 -/-embryos were identified at E11.5, having been partially reabsorbed. Occasional viable embryos were found at E10.5 with beating hearts and significant growth retardation. At day E9.5, the distribution of Has2 -/-embryos approaches mendelian frequency ( Table 1) . Analysis of embryonic mRNA by RT-PCR revealed only truncated transcripts of the expected length, with no full-length mRNA expressed in Has2 -/-embryos (data not shown). Although we have developed anti-peptide antibodies recognizing recombinant Has2 (6), we cannot detect Has2 protein by immunoblotting extracts of embryonic wild-type mice (data not shown). However, the truncated transcript interrupts the sequence encoding the intracytoplasmic catalytic domain. Thus, any protein product would lack HA synthase activity.
The Has2 -/-embryos exhibited growth retardation and scant numbers of red blood cells, and lacked vitelline vessels in the yolk sac ( Figure 3, a and b) . The heart was thinwalled and relatively bloodless, and often exhibited marked pericardial swelling (Figure 3f ). The visceral endoderm and mesoderm forming the yolk sac was not fused except at discrete foci (see insets in Figure 3a Has2 -/-embryos beat with a distinctive to-and-fro motion of red blood cells. This is consistent with absent AV cushions as well as partial or complete obstruction of the outflow tract. Somites were present, albeit distorted, and other structures including the first pharyngeal pouch and otic placodes were also present ( Figure 3 , c and d). Some of the E9.5 Has2 -/-embryos had failed to turn, and exhibited posterior defects as well as cephalic mesenchyme abnormalities (data not shown). Wholemount immunostaining for PECAM, a marker for endothelial cells, revealed a marked reduction in vessels in Has2 -/-embryos (compare Figure 3f with Figure 3e ). Has2 is required for HA production at E9.5 and for cardiac morphogenesis. Has2 -/-embryos have strikingly compacted extracellular space, and do not stain with alcian blue for acidic glycosaminoglycans (Figure 4, a and b) . A specific biotinylated probe verified the absence of HA (Figure 4d) . Quantitative analysis of pooled embryos using FACE analysis demonstrated a 96% reduction in HA in Has2 -/-embryos compared with wild-type littermates (Table 2 ). An image of a representative FACE analysis is shown in Figure 5 . Wild-type littermates ( Figure 5 , lanes 2 and 3) clearly yield much higher levels of the fluorescent disaccharide ∆DiHA (which is specific to HA) than do the Has2 -/-embryos ( Figure 5, lanes 4 and 5) . Other extracellular-matrix components, including collagen I, fibronectin, laminin, and versican were all present in Has2 -/-embryos. However, their organization was altered in the compacted extracellular spaces (data not shown). The heart lacked cardiac jelly and cushions, although there was a characteristic constriction in the region of the AV canal (Figure 4b, arrows) . The myocardium lacked trabeculae even though the ventricular wall was several cell layers thick. These observations confirmed a lack of HA production, compaction of the extracellular space, and lack of endocardial cushions and trabeculae in the hearts of Has2 -/-embryos.
Scanning electron microscopy revealed surface and internal detail of the hearts of wild-type and Has2 -/-embryos ( Figure 6 ). In the wild-type heart at E9.5, the common atrium has moved dorsal and anterior to the ventricle. The left and right ventricles are becoming distinct, and the outflow tract is dividing into the aortic and pulmonary vessels by formation of the aortopulmonary septum (Figure 6b) . The heart from an Has2 -/-embryo has a small atrium, a swollen pericardial space (Figure 6e) , and marked reduction of the right ventricle and outflow tract ( Figure 6, d-f) . The wild-type heart has AV cushions and trabeculation of the ventricle myocardium, whereas the Has2 -/-embryo lacks endocardial cushions and has a compacted ventricle wall devoid of trabeculations ( Figure 6, i and j) .
The Has2 -/-phenotype closely resembles that of the hdf mouse (27) , which lacks versican, an HA-binding proteoglycan (28) . Examination of Has2 and versican mRNAs by in situ hybridization reveals that both are expressed in the heart (Figure 1, a-d) . Moreover, the cardiac jelly is rich in HA and versican (Figure 1, f and  g ). Thus, the common phenotype resulting from disruption of the Has2 and versican genes demonstrates that both matrix molecules are essential for formation of cardiac jelly and endocardial cushions.
Transformation of cardiac endothelium to mesenchyme does not occur in the absence of Has2 and is restored by adding exogenous HA or by expressing Has2 cDNA. At 4-5 weeks gestation in the human, and by E9-10 in the mouse, the cardiac jelly expands rapidly in the AV canal and outflow tract, forming the cardiac cushions. Initially, the AV cushions function as valves ensuring unidirectional blood flow. Then, a subset of endothelial cells lining the cushions detaches from adjacent cells, migrates, and transforms into mesenchymal cells that invade and remodel the cushions into the tricuspid and mitral valves and the membranous portion of the interventricular septum. This process requires soluble signals released from the underlying myocardium interacting with receptor tyrosine kinases in the endothelium (29, 30 ). We could not assess AV canal formation in situ because of the absence of cushions in Has2 -/-embryos. However, in vitro collagen gels support endothelium-to-mesenchyme transformation of AV canal explants, duplicating the in situ events in AV canal morphogenesis. This system has been extensively validated and used to elucidate the signals regulating AV canal development (30) (31) (32) (33) . In vitro, this process is characterized by migration of endothelial (endocardial) cells as an epithelial sheet, followed by retraction and separation of the endothelium ("activation"). Finally, the activated endothelial cells undergo transformation, invading the underlying collagen gel and expressing a repertoire of mesenchymal genes de novo, such as α-smooth muscle actin. For clarity, we will refer to the entire process as AV canal morphogenesis, and will refer to each step with the terms "endothelial migration," "activation," and "transformation." It is important to
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The recognize that most published studies of in vitro AV canal morphogenesis use the chick. In the mouse, we find that formation of a distinct endothelial sheet occurs only in AV canal explants from embryos at E10-10.5. We studied E9.5 embryos to avoid artifacts associated with the morbidity of the Has2 -/-embryo. At this age, a definitive endothelial sheet is rarely seen (Camenisch et al., unpublished results). In AV canal explants from E9.5 wild-type embryos, numerous endothelial cells migrated over the surface of the collagen gel, transformed, and invaded the gel matrix ( Figure 7, a and b) . The mesenchymal cells expressed characteristic mesenchymal markers, including fibulin-1 and fibulin-2 (data not shown) (34, 35) . In contrast, endothelial-cell migration was absent in AV canal explants from Has2 -/-embryos (Figure 7d) . The production of diffusible signaling molecules by the myocardium (33, 36, 37) and the responsiveness of the endothelial cells to signals are temporally and spatially regulated (29) . Either (or both) could be deficient in Has2 -/-embryos. However, if migration or transformation were lacking solely due to the absence of HA, then providing exogenous HA or restoring Has2 function should correct the defect. To test this, we transfected Has2 -/-explants with Has2 cDNA. An empty control vector had no effect on migration or transformation in Has2 -/-explants (Figure 7d ), whereas transfection with Has2 cDNA restored both migration and transformation ( Figure  7e) . Moreover, supplementing the culture medium (Figure 7f) or the collagen gel with HA (Figure 7g ) also restored the normal phenotypic response in Has2 -/-AV explants. Interestingly, exogenous HA was fully effective at ng/mL concentrations, implicating a high-avidity interaction mediating its biological effects (data not shown). (Boiling the HA had no effect on its ability to restore AV canal morphogenesis in vitro.) Finally, conditioned medium from AV explant cultures from wild-type embryos also restored migration, epithelium-to-mesenchyme transformation, and invasion in Has2 -/-AV explants (data not shown). The Table 1 ).
hyaluronidase (data not shown). The rescue of endothelial migration and transformation in AV explant cultures from Has2 -/-hearts demonstrates that neither the production of defined transforming activity by the myocardium (i.e., TGF-β) nor endothelial-cell competence is deficient in Has2 -/-embryos. The simplest interpretation is that HA is required for migration and possibly for subsequent transformation of the endothelial-cell population into mesenchyme. Notably, AV canal endothelial migration, transformation, and invasion is not affected in versican-deficient hdf mice, despite their lack of cardiac jelly (27) .
The requirement for HA in AV canal morphogenesis is removed by expressing constitutively active Ras, and HA-mediated AV canal morphogenesis in vitro requires Ras. Unregulated Ras activity leads to hyperproliferation of mesenchymal cells and AV cushion defects (30) . We assessed the effect of expressing dominant-negative Ras in AV canal explants. Dominant-negative Ras significantly reduced the migration and transformation of endothelial cells in wild-type AV canal explant cultures, mimicking the Has2 -/-phenotype (Figure 7c ). Thus, a pathway acting through Ras is important for transformation and invasion by cardiac endothelium. Next, we tested whether expressing constitutively active Ras could negate the requirement for HA in AV canal morphogenesis in explants from Has2 -/-embryos. Active Ras restored the normal phenotypic response in Has2 -/-AV explants to wild-type levels (Figure 7h) . Thus, expression of activated Ras circumvents the requirement for HA in migration and epithelium-to-mesenchyme transformation. Finally, to determine if exogenous HA is acting via pathways involving Ras activation, we assessed the effect of inhibiting Ras on migration and transformation in Has2 -/-explants treated with HA. As shown in Figure 8 , dominant-negative Ras significantly inhibited transformation mediated by HA in Has2 -/-explants. The endothelial cells adopted an epithelial phenotype and migrated over the collagen gel, but did not transform into mesenchyme or invade the collagen gel. This result suggests that a pathway requiring HA and leading to Ras activation is essential for endothelial transformation during AV canal morphogenesis. Endothelial migration, although dependent upon HA, occurs irrespective of Ras activity.
Discussion
Has2 is the major source of HA during embryogenesis, and HA is essential in cardiac organogenesis. The lethality in Has2 -/-embryos underscores the critical role of HA in cardiovascular morphogenesis and demonstrates that Has2 is the major source of HA during this period of embryonic development. A functional cardiovascular system is required to sustain life beyond E9. 5-10 (38) . HA appears at E5.5 in the yolk cavity, and by E6.5 is present in all embryonic cavities, the embryonic and extraembryonic mesoderm, and the allantois (16, 17) . Either another Has gene (i.e., Has1 or Has3) must function earlier in development to replace Has2 function, or HA is dispensable before cardiac morphogenesis; this is currently being evaluated. Phenotypically, we cannot distinguish Has2 -/-embryos earlier than approximately E8.5. Targeting of the other Has genes has been accomplished, and Has1 -/-and Has3 -/-animals are viable and fertile (unpublished data). Furthermore, compound Has1, Has3 homozygous-null mice are viable and fertile, underscoring the pivotal role of Has2 during embryogenesis. We are currently creating Has1 -/-, Has2 +/-, Has3 -/-animals to assess whether haploinsufficiency occurs with only one functional Has2 allele.
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The There are profound defects in vasculogenesis in the Has2 -/-embryos involving the yolk sac and systemic vasculature. Similar abnormalities are seen in the yolk sacs of mice lacking molecules that mediate cell-matrix and cell-cell interactions, including α5-integrin (39) and Ncadherin (40) . Interestingly, yolk sac pathology is seen in mice that lack N-Ras function and are heterozygous for a null mutation in K-ras (41) . These abnormalities can also be associated with pericardial edema (38), but we believe that the vascular abnormalities result from the absence of HA, because despite near-identical cardiac phenotypes, hdf mice do not have yolk sac defects (Corey Mjaatvedt, personal communication). The early lethality of Has2 -/-embryos makes it difficult to directly assess the role of Has2 in the development of other embryonic structures. This will require more sophisti- 
Figure 7
AV canal morphogenesis is deficient in Has2 -/-AV canal explants and is restored by exogenous HA or activated Ras. Top panel: AV canal explant morphogenesis in vitro. AV canal explants from E9.5 wild-type (a-c) or Has2 -/-embryos (d-h) were cultured on collagen gels. Explants from wild-type embryos exhibit abundant endothelial cell migration and invasion (image a is focused on the surface of the gel; b is focused below the surface). In contrast, there is no endothelial-cell migration in AV canal explants from E9.5 Has2 -/-embryos (d). Transfection with dominant-negative (DN) Ras cDNA significantly (P < 0.001) reduces endothelial migration and invasion in AV explants from wild-type embryos (c).
Because migration and invasion begins during the 16-hour incubation before transfection, the degree of inhibition is probably underestimated (see Methods). AV canal explants from Has2 -/-embryos exhibit comparable morphogenesis after transfection with Has2 cDNA (e), in the presence of HA in the media (f), or in the collagen gel (g). Transformation in Has2 -/-embryos is also rescued by transfecting with constitutively active Ras (h). M, myocardium. Nomarski DIC optics. Bar in h = 200 µm. Bottom panel: Quantification of AV canal transformation in the presence or absence of either dominant-negative Ras (S17N) or constitutively active Ras (Q61L). The dominant-negative Ras significantly inhibited cell migration and invasion in viable wild-type explants, whereas constitutively active Ras restored cell migration and invasion in AV explants from Has2 -/-embryos to the same degree as wild-type explants. The scoring method is outlined in Methods. A P < 0.001.
cated in vivo genetic approaches, such as generation of chimeric animals or tetraploid rescue. A composite matrix is required for expansion of the extracellular space during cardiac cushion formation. Abnormal formation of the endocardial cushions results in AV septal defects, the second most common cardiac defect in infants (42) . The similar phenotype of HA-deficient Has2 -/-and versican-deficient hdf mice reveals for the first time the critical importance of a composite matrix containing HA in AV canal morphogenesis. Clearly, neither molecule alone is sufficient for this process. HA interacts with other matrix molecules, including inter-α-trypsin inhibitor (43), link protein (44) , and fibulins (45) . Fibulin is present in cardiac cushions (34) , and binds both HA and versican (45) . These interactions, in conjunction with our observations, underscore the diversity and potential importance of composite matrices in the development of the AV cushions. The expression of endocardial cushion matrix components in the AV canal is probably controlled by activity of upstream transcription factors implicated in cardiac morphogenesis. Potential candidates include the basic HLH transcription factor Hand2, which is required for proper morphogenesis of the right ventricle and outflow tract/conus (46, 47) , and epicardin, another basic HLH transcription factor (48) . We are currently analyzing the Has2 gene locus for regulatory elements that are responsible for Has2 expression in the developing heart.
HA is required for endothelial-cell migration and transformation in AV canal morphogenesis. A striking and unexpected outcome of our studies is the requirement for HA in cell migration, transformation, and subsequent invasion. Whereas previous studies have implicated HA in cardiac development (31, 49, 50) , our investigation demonstrates an absolute requirement for HA during AV canal morphogenesis in vivo and in vitro. This is the first report of a developmental system in which cell migration and transformation have an absolute dependence on HA. The fact that dominant-negative Ras inhibits endothelial cell migration and transformation in normal AV explants confirms the requirement for Ras activity during AV morphogenesis (30) . Moreover, constitutively active Ras circumvents the requirement for HA in endothelial-cell transformation in Has2 -/-embryo explants. Finally, we show that the ability of HA to rescue normal endothelial transformation to mesenchyme in Has2 -/-AV canals is inhibited by dominant-negative Ras. This indicates that the HA induction converges on Ras activation during transformation of these cardiac endothelial cells. Interestingly, treatment of Has2 -/-AV explants with HA in the presence of dominant-negative Ras supports endothelial cell migration, but not transformation (Figure 8) . Therefore, endothelial cell migration is independent of active Ras signaling, but is still dependent on HA. Therefore, two sequential steps require HA: migration of endothelial cells, which may not require Ras, followed by their transformation into mesenchyme, which appears to require Ras signaling.
What is the mechanism through which HA acts? One possibility is that HA binding to a cognate receptor, e.g., CD44, activates downstream pathways that converge on Ras activation. Although CD44-deficient mice are not reported to exhibit any cardiovascular phenotype (51), we have observed retarded endothelial-cell transformation in vitro with AV explants from CD44 -/-embryos (data not shown), as well as partial inhibition of transformation using a monoclonal antibody blocking CD44-HA binding (52) . Additionally, HA may serve as a costimulatory molecule acting in concert with known receptor-mediated signaling pathways. This is a well accepted paradigm for integrin matrix receptors, which act synergistically with growth factor receptors (53) (54) (55) (56) . Given the ubiquitous distribution of HA in cardiac jelly and the sharply restricted domain of endothelial-cell transformation, we favor the latter hypothesis. Provocatively, mice with null mutations in either an ErbB ligand, heregulin-1 (neuregulin-1), or in the cognate receptors ErbB3 and ErbB4 exhibit cardiac phenotypes resembling those of the Has2 -/-and hdf embryos (57) (58) (59) . Heregulin-1 is expressed in AV canal endothelial cells; ErbB3 is expressed in the subjacent AV canal mesenchyme (57) . Binding of HA to CD44 activates Ras cooperatively with members of the receptor tyrosine kinase ErbB family (21, 60) , and HA activates mitogenactivated protein kinase via Ras (61) . HA binding to CD44 also activates Rac1 and promotes formation of lamellipodia in mouse epithelial cells (62) . Collectively, these observations suggest that an HA-dependent, receptor-mediated signaling event involving HA, CD44, and ErbB receptors/ligands may be essential for AV canal morphogenesis. Collectively, our data indicate that HA acts by stimulating intracellular signaling path-
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The ways, including Ras, and that additional or alternative receptors for HA may compensate for CD44. Our results demonstrate that HA plays two distinct and complementary roles during AV canal morphogenesis. First, HA is a necessary component of the extracellular supramolecular array expanding the extracellular matrix, a requisite for formation of cardiac jelly and the endocardial cushions. Second, although the cognate receptor (or receptors) must be defined, HA acting in concert with additional factors stimulates the Ras-dependent intracellular signaling that is necessary for endothelial cell transformation to form mesenchymalized cushions. These observations reveal a novel mechanism in which an extracellular matrix component, HA, acts through a receptor complex to induce Ras-dependent signaling and cell transformation. It remains to be seen whether HA plays similar, dual roles in the development of other embryonic structures and in tumor progression by expanding the extracellular space and inducing cell migration and transformation.
